Bell Spring - Headache Relief
Natural health product licensed in Canada
- Other names
- Arboland - Bell Spring - Headache Relief, Arboland - Bell Spring - Headache Relief Functional Care Blend, Arboland - Bell Spring - Headache Remedy, Arboland - Bell Spring - Headache Remedy Functional Care Blend, Bell Spring - Headache Relief Functional Care Blend, Bell Spring - Headache Remedy, Bell Spring - Headache Remedy Functional Care Blend
- Licence holder
- Arboland Wellness Inc.
- NPN or DIN-HM
- 80084345
- Status
- Inactive licence
- Licence date
- 10 April 2018
- Revision date
- Not provided
- Form
- Huile
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| Eucalyptus globulus Source : Feuille | 36.67 % |
| Mentha x piperita Source : Rameaux en fleurs | 13.33 % |
| Lavandula angustifolia Source : Sommité en fleurs (herbe) | 20 % |
| Origanum majorana Source : Sommité en fleurs (herbe) | 3.33 % |
| Chamaemelum nobile Source : Sommité | 2.17 % |
| Cinnamomum camphora Source : Bois | 5 % |
Non-medicinal ingredients
Huile de pépin de raisin
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 18 years | Not specified | Not specified |
Uses authorised in Canada
Used in aromatherapy to help relieve headache.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience nausea, dizziness, headache or an allergic reaction, discontinue use.
- Contre-indications
If you are pregnant or breastfeeding, do not use this product. If you have broken, irritated, or sensitive skin, do not use this product.
- Précautions et mises en garde
Keep out of reach of children. If accidental ingestion occurs, seek urgent medical attention or contact a Poison Control Center. If symptoms persist or worsen, consult a health care practitioner. If you have epilepsy or asthma, consult a health care practitioner prior to use. Do not expose the applied area(s) to the sun for 24 to 48 hours after application.
Source
Official Health Canada record, licence 80084345
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.